Clever Leaves Holdings Inc.

CLVR Healthcare Drug Manufacturers Specialty & Generic

Clever Leaves Holdings Inc.’s revenue for fiscal 2023 (year ended December 2023) was $17.4 million, up 6.14% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.

0.01 0.00 0.00%
Market cap
$96.5M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−9.41
Beneish M
−3.86
Dividend safety
n/a
Older periods Mar '23 Jun '23 Sep '23 Dec '23
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.09 0.56 0.29 0.19
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(2.76) (5.38) (2.24) (2.11)
P/B ratio
0.46 0.27 0.17 0.13
EV/Sales
0.75 0.33 (0.02) (0.14)
EV/EBITDA
0.00 0.00 0.02 0.19
EV/FCF
(0.46) (0.30) 0.02 0.28
Current Ratio
2.71 2.43 2.62 2.40
Net Debt/EBITDA
1.49 1.47 2.36 1.27
Debt/Equity
0.04 0.04 0.05 0.05
Earnings Yield
(330.17%) (647.02%) (903.05%) (543.51%)
Free Cash Flow Yield
(148.60%) (198.49%) (240.87%) (266.05%)
Free Cash Flow per Share
(4.18) (1.16) 0.33 (0.86)
Book value per Share
25.15 22.72 18.79 15.44
Free Cash Flow
(6.11) (1.73) 0.52 (1.35)
EV/EBIT
0.00 0.00 0.02 0.16
Other line items

Show all line items

Columns are period end dates